A5006428495- HIV Research and Treatment
- Immune Cell Function and Interaction
- HIV-related health complications and treatments
- Cytomegalovirus and herpesvirus research
- Antimicrobial Peptides and Activities
- Genetic Neurodegenerative Diseases
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
- Neurological and metabolic disorders
- Herpesvirus Infections and Treatments
- Parvovirus B19 Infection Studies
- CRISPR and Genetic Engineering
- Mosquito-borne diseases and control
- Autoimmune Neurological Disorders and Treatments
- Mycobacterium research and diagnosis
- Hepatitis C virus research
- Leprosy Research and Treatment
- HIV/AIDS Impact and Responses
- Pneumocystis jirovecii pneumonia detection and treatment
- Syphilis Diagnosis and Treatment
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
2012-2021
Instituto Nacional de Enfermedades Respiratorias
2020
Weatherford College
2020
AIDS Vaccine Advocacy Coalition
2009
In 2004, the World Health Organization performed a survey to assess transmitted drug resistance in Mexico City among drug-naive persons with newly diagnosed human immunodeficiency virus (HIV) infection and likely be recently infected who were attending 3 voluntary counseling testing sites. A parallel study comparing 2 alternative methods of enrolling participant was conducted 9 sites central Mexico. arm 1, subject information, consent blood specimens obtained during HIV diagnostic visit. 2,...
ObjectivesThe aim of this study was to investigate the correlation between HIV-1 reservoir and levels immune activation in chronic patients under fully suppressive cART.MethodsWe quantified HIV proviral DNA 2-LTR circles loads from PBMCs, CD38+ Ki-67+ T-cells, IL-7 a cohort with more than 5 years ART at enrollment after 1 year.ResultsIn 29 participants median 8 (IQR, 6.9-9.4) cART we found higher CD8+ T-cells 1-year (P = .000). There non-statistically significant poor CD4+ T-cells. declined...
We present a cohort of individuals who reached CD4+ T cell counts greater than 1,000 cells/mm3 (Hypers) after starting antiretroviral treatment (ART) and compared them with those between 350 999 (Concordants). Demographic data, immune recovery kinetics, subset phenotypes, integrated HIV DNA were analyzed. Data from living on their first ART regimen 48 months follow-up obtained. Immune phenotype by Flow Cytometry analysis whole blood was performed, cytokines measured, HIV-1 measured...
Opsoclonus-myoclonus-ataxia (OMA) syndrome is a rare neurological disorder characterized by involuntary conjugate saccadic eye movements, myoclonus, and ataxia. Few reports exist on patients with HIV OMA.A 41-year-old man diagnosed HIV-1 infection in 1997 coursed multiple anti-retroviral schemes as consequence of poor adherence. In 2008 he presented an viral load 100,000 copies/mL CD4+ T cell count 10 cells/mm3. 2013 our patient arrived 11-month history progressive opsoclonus He had...
Abstract Background The main cause of the persistently high levels immune activation in HIV positive patients undergoing suppressive chronic cART is still unknown. Previous findings have suggested a link between ongoing residual viral replication originating from reservoir and levels. However, there no clear evidence this assumption. aim study was to investigate correlation under fully cART. Methods We conducted prospective longitudinal cohort for more than 5 years without any documented...